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Abstract
Background: The study was conducted to investigate the diagnostic performance of infrared (IR) imaging of the
breast using an interpretive model derived from a scoring system.
Methods: The study was approved by the Institutional Review Board of our hospital. A total of 276 women (mean
age = 50.8 years, SD 11.8) with suspicious findings on mammograms or ultrasound received IR imaging of the
breast before excisional biopsy. The interpreting radiologists scored the lesions using a scoring system that
combines five IR signs. The ROC (receiver operating characteristic) curve and AUC (area under the ROC curve) were
analyzed by the univariate logistic regression model for each IR sign and an age-adjusted multivariate logistic
regression model including 5 IR signs. The cut-off values and corresponding sensitivity, specificity, Youden’s Index
(Index = sensitivity+specificity-1), positive predictive value (PPV), negative predictive value (NPV) were estimated
from the age-adjusted multivariate model. The most optimal cut-off value was determined by the one with highest
Youden’s Index.
Results: For the univariate model, the AUC of the ROC curve from five IR signs ranged from 0.557 to 0.701, and
the AUC of the ROC from the age-adjusted multivariate model was 0.828. From the ROC derived from the
multivariate model, the sensitivity of the most optimal cut-off value would be 72.4% with the corresponding
specificity 76.6% (Youden’s Index = 0.49), PPV 81.3% and NPV 66.4%.
Conclusions: We established an interpretive age-adjusted multivariate model for IR imaging of the breast. The cut-
off values and the corresponding sensitivity and specificity can be inferred from the model in a subpopulation for
diagnostic purpose.
Trial Registration: NCT00166998.
Background
Infrared (IR) imaging of the breast, also known as breast
thermography, is a non-invasive, painless examination
which does not expose the subject to ionizing radiation,
and is mainly a test of physiologic response of the breast
findings [1-6]. It is based on the mechanism that the
skin temperature overlying a malignancy is higher than
skin overlying normal breast tissue. This is due to
increasing infrared radiation and is most likely caused
by elevated blood flow, metabolic activity, and
angiogenesis at and around the lesion site [2,5]. IR ima-
ging has been used for breast cancer detection since the
1970s [1,2]. A nationwide study, Breast Cancer Detec-
tion Demonstration Projects (BCDDP) launched in
1973, investigated breast cancer screening by clinical
breast examination, mammography and IR imaging.
However, IR imaging was dropped at an early stage of
the project due to unsatisfactory results [1-4]. This may
have been due to technical difficulties, widely variable
and subjective interpretation among image readers,
unacceptably high false-positive and false-negative rates,
and no direct aid for spatial localization of surgery [1-4].
However, abnormal findings on IR imaging of the breast
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predictor for breast cancer, and IR imaging can also be
an aid in the differential diagnosis of benign from malig-
nant tumors [1,3,6-10]. The aforementioned values can
be facilitated by modern computerized IR technology
[1,3,6,7,10-12]. On the other hand, the diagnostic cri-
teria varied among studies an dt h ed i a g n o s t i cp e r f o r -
mance, including sensitivity and specificity, also varied.
Herein, we investigated the diagnostic performance of
computerized breast IR imaging using an integrated
interpretative model for breast IR imaging.
Methods
Patients
The study was approved by the Institutional Review
Board of our hospital, and all study participants signed
informed consents before the study. We enrolled 276
women (ages 17-81 years, mean = 50.8 years, SD = 11.8
years, median 50 years) who were scheduled to undergo
excisional biopsy for suspicious findings on mammo-
grams or ultrasound, or both. Patients with probably
benign findings on mammography or ultrasound but
received excisional biopsy due to surgeons’ concerns
were also included. IR imaging of the breast was done 1
day before surgery. Before enrolling subjects into this
study, we excluded women who had a past history of
breast surgery or chest irradiation, or systemic che-
motherapy. The participants had to refrain from smok-
ing, alcohol drinking, vigorous exercise, and application
of lotion to the breasts within 4 hours before the proce-
dure. Patients who received fine needle aspiration within
2 days or core needle breast biopsy within 2 weeks or
any of who received vacuum-assisted breast biopsy
before the study were also excluded.
Procedures
Computerized IR examination was done by two trained
female radiological technicians using a medical thermo-
graphic system (ATIR-M301 Thermal Imaging System,
Associated Technology Corporation, Chongqing,
Sichuan, PROC), which was an uncooled micro-bol-
ometer with focal plane array detector, and the image
matrix size was 320 × 240 with 14-bit depth, the pixel
size was 45 × 45 μm with the response wave length 8-
12 μm, and the temperature resolution was less than
0.1°C. The procedure was done in a temperature con-
trolled room maintained between 23 and 25°C. Each
participant was asked to disrobe and sit on a chair in an
erect position, with hands over the head, sitting a dis-
tance about 2.5 meters away from the IR camera. After
a total of 15 minutes rest, frontal, two true lateral (left
and right lateral) and two oblique (left and right obli-
que) views of IR images were taken.
Imaging processing and interpretation
The images were viewed with a dedicated software pro-
gram (M301-APP-V2.0, Associated Technology Corp.,
Chongqing, Sichuan, PROC) with manual brightness
and contrast adjustment, and were displayed with either
a gray-scale or a preset colored-scale.
A radiological technician and a radiologist (first radiol-
ogist) marked the lesion location and size of the lesions
of concern, based on conventional imaging modalities
including mammography, ultrasound, or both. They
recorded the above information for each lesion on a
sheet for the reference of the interpreting radiologists.
Other two radiologists (second and third radiologists)
were assigned to interpret the IR images; each read half
of the cases. They interpreted the assigned IR images
based only on the information of the above-mentioned
sheet. The detailed mammographic and ultrasono-
graphic, final pathologic findings of the study cases were
only known to the first radiologist and were not avail-
able to the two IR imaging readers. The two radiologists
who interpreted the IR images were both specialized in
the field of breast imaging for more than 10 years.
The interpreting radiologists read the IR images based
only on the findings at the lesion sites of concern and
scored the findings according to the five independently
diagnostic IR signs modified from the Ville Marie Infra-
red (IR) grading scale [7] and other reported literature
[13-15]. The readers then recorded individual scores for
each diagnostic IR sign for each lesion. We defined the
IR signs as follows (Figures 1, 2, 3, &4):
IR1: a difference in surface temperature (dT) at the
lesion site from that at the mirror image site on the
contralateral breast; the IR1 scale was scored as 0 for
Figure 1 A 76-year-old woman with left breast cancer.I R
imaging reveals focal increased surface temperature (positive IR1
sign with dT = 1.5°C compared with the contralateral mirror image
site; positive IR2 sign with dT = 2°C compared with the remaining
breast tissue at the ipsilateral side), abnormal vascular pattern (IR3
signs including closed vascular pattern, and vascular completeness)
(arrows) and asymmetric vascular pattern (IR5 sign), and subtle focal
bulging with back heat (IR4 sign) in left lower breast (arrowheads).
Surgical pathological finding revealed a 4 cm infiltrating ductal
carcinoma.
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2°C.
IR2: the dT between the lesion site and the rest of the
normal breast tissue of the ipsilateral breast; the IR2
scale was scored as 0 for dT <= 1°C, and as 1 for dT >
1°C.
IR3: a combination of 8 various abnormal vascular
patterns, including star vessel, inverted V vessel, frag-
mented vessel, closed vessel, vascular completeness,
pointed or bifurcated vessels, moa-moa vascular pattern,
or transverse vascular pattern [14]. Of them, the star
vessels indicated vessels with radiating pattern and star
shape; the fragmented vessels indicated that fragmented
vascular anarchy in a localized area of the breast; closed
vessel indicated vascular anarchy arranged in a closed
pattern without evident branching; pointed or bifurcated
vessels indicated vessels with pointed or bifurcated ends;
moa-moa sign indicated a focal area of abnormal vascu-
lar pattern with irregular and engorged vascular branch-
ing with its shape mimicking a moa; transverse vascular
pattern indicated a vessel which traverses part of the
breast with a relatively somewhat horizontal or trans-
verse orientation [14]. The presence of any of the above
signs was scored as 1 and the absence of such signs as
0 .T h es u mo ft h ee i g h ts i g n sw a st h es c o r ef o rt h eI R 3
sign, which ranged from 0 to 8 and was treated as a
continuous variable.
IR4: an edge sign or bulge sign backed by heat, indi-
cating loss of smooth contour of part of the breast due
to skin retraction or bulging caused by a breast tumor
[16], the IR4 was scored as 0 when the sign was absent
and as 1 when the sign was present.
IR5: the presence of an asymmetric or heterogeneous
vascular pattern at and around the lesion site, when the
contralateral breast did not reveal such a pattern. The
IR5 scale was scored as 0 if the sign was absent and 1 if
the sign was present.
Statistical Analysis
We analyzed the correlation of the diagnostic IR signs
with the final disease status of the lesions at surgery
using univariate and multivariate logistic regression ana-
lyses by SAS software (SAS version 9.00, SAS Institute,
Cary, NC, USA) and SPSS software (SPSS version 16.0,
SPSS Inc., Chicago, IL, USA). We categorized the final
disease status as a dichotomous variable, that is, benign
(including high risk lesions) or malignant. The high-risk
Figure 2 The corresponding breast ultrasound of the patient in
Figure 1 shows a lobular mass at left lower breast, measuring
about 3.1 × 2.1 cm in diameter with heterogeneous
echogenicity (arrows).
Figure 3 A 48-year-old woman with right breast cancer.I R
imaging shows abnormally increased focal surface temperature
(positive IR1 sign with dT = 1.2°C compared with the contralateral
mirror image site; positive IR2 sign with dT = 2°C compared with
the remaining breast tissue in the ipsilateral breast), abnormal
vascular pattern (IR3 signs including bifurcated vascular pattern,
transverse vascular pattern, vascular completeness) and an
asymmetric vascular pattern (IR5) in the right upper breast (arrows).
The ln(OD) value for this finding scored by the interpreting
radiologist was: -5.463+0.0872(48)+0.3783(1)+1.9157(0)+0.1728(1)
+0.1578(3)+1.0278(0)+1.0363(1) = 0.7834, which is higher than the
most optimal cut-off point (0.30) we selected in Table 4, and this is
test-positive based on this cut-off point. (The radiologist scored the
IR1 scale for this lesion as 1, therefore, the IR1A = 1 and IR1B = 0).
Figure 4 The right magnified mammogram of the patient in
Figure 3 shows segmental pleomorphic microcalcifications in
right upper breast (arrows).
Wang et al. BioMedical Engineering OnLine 2010, 9:3
http://www.biomedical-engineering-online.com/content/9/1/3
Page 3 of 10lesions in our study included ADH (atypical ductal
hyperplasia), ALH (atypical lobular hyperplasia), and
papillary lesions.
For the univariate logistic regression analysis, we
investigated the association of each individual IR sign
with the final disease status. For the multivariate regres-
sion model, we put the five IR signs of each lesion into
the model with age adjustment. The AUC (area under
the ROC curve) values of the ROC (receiver operating
characteristic) curves for each IR sign from the univari-
ate model and for the age-adjusted multivariate model
were estimated in order to investigate the diagnostic
performance of the IR imaging. The Hosmer and Leme-
show test was applied to inspect the goodness-of-fit of
the age-adjusted multivariatem o d e l ,a n dan o n - s i g n i f i -
cant p value (>0.05) implies that the model is a fitted
model. The age-adjusted multivariate model was pre-
sented as shown below:
Where ln indicated the natural logarithm. The P value
indicated the predicted probability of a lesion being
malignant estimated from the regression model. There-
fore, the P/(1-P) ratio indicated the odds (OD), that is,
the ratio of the probability of being malignant to being
benign for a given lesion. a is the intercept of the
model. However, since IR1 is a trichotomous categorical
variable, we re-coded the IR1 sign as a dummy variable
for computations in logistic regression. That is:
i ft h eI R 1s c a l eo fag i v e nl e s i o nw a s0( d T< =1 ° C ) ,
then the (IR1A, IR1B) = (0, 0);
if the IR1 scale was 1 (1°C<dT <= 2°C), then the
(IR1A, IR1B) = (1, 0);
if the IR1 scale was 2 (dT>2°C), then the (IR1A,I R 1 B)
= (0, 1).
In addition, bi values (where i = 0, 1A,1 B,2 ~ 5 )i n d i -
cated the regression coefficients for each IR sign and
age factor under this multivariate regression model. IR2
to IR5 in this model indicated the scales for IR2 to IR5
signs of each lesion scored by the interpreting
radiologists.
Further, we substituted the age and IR scales read by
the radiologists into the age-adjusted multivariate
regression model, thus obtaining the ln(OD) of each
lesion. The cut-off values were derived and selected
from the ln(OD) of this model. Under a given cut-off
point or threshold, the ln(OD) of a lesion higher than or
equal to the threshold implied a positive IR-test. For
each given cut-off point, we also estimated the corre-
sponding sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV), and Youden’s
Index (Index = sensitivity+specificity-1) [17,18]. The
selection of cut-off points in our study was based on the
criteria shown below:
For the cut-off values with sensitivity >90%, we
selected one of them with highest corresponding specifi-
city as the lowest cut-off value. Among those cut-off
values with specificity>90%, we selected the one with
highest corresponding sensitivity as the highest cut-off
value. The cut-off value with the highest Youden’s Index
was also included in the analysis and was regarded as
the most optimal cut-off point in our study. We also
included other cut-off values between the highest and
lowest cut-off values mentioned above, and a total of 5
cut-off values were taken for analysis.
We also evaluated the BI-RADS® (Breast Imaging
Reporting and Data System) categories [19] of lesions
on mammography and ultrasound, and the correspond-
ing true disease status (the histopathologic results). If
the patient received only mammography or ultrasound,
the BI-RADS® category of the lesion was determined by
one of the imaging modalities; if the patient received
both examinations, the BI-RADS® category was given
based on higher concern between the two imaging mod-
alities. Based on the most optimal cut-off point and the
cut-off value with the highest sensitivity we selected, the
corresponding sensitivity, specificity of IR imaging in
each BI-RADS® category were also estimated. Since
breast cancer may be inherently a life-threatening dis-
ease and the false-negativity (1-sensitivity) would cause
severe consequences in clinical practice of breast ima-
g i n g ,t h e r e f o r e ,w ea l s oi n c l u d e dt h es e l e c t e dc u t - o f f
value with highest sensitivity for detailed analysis.
Based on the age-adjusted multivariate model, the ln
(OD) values of malignant and benign foci for all lesions
were compared using Student’s t-test. For the lesions
with mammographic findings available for correlation,
we categorized them into three major types of mammo-
graphic findings, that is, microcalcifications, microcalci-
fications associated with mass (or architectural
distortion, focal asymmetry), or noncalcified lesions. We
also investigated if there was any difference in ln(OD)
values between malignant and benign lesions for differ-
ent types of mammographic findings using Student’s t-
test or non-parametric Mann-Whitney U test.
We further stratified all lesions into three categories
according to the pathologic size, that is, size larger than
or equal to 2 cm, size less than 2 cm but not less than 1
cm, and size less than 1 cm across the largest diameter.
We compared the ln(OD) values for lesions between
benign and malignant lesions for these three categories
by Student’s t-test or Mann-Whitney U test, in order to
investigate the validity of the age-adjusted multivariate
model in lesions with different size categories.
In our study, a p value less than 0.05 was considered
to show statistical significance.
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In our study, a total of 298 lesions associated with 276
patients were excised with histopathological correlation.
The clinical, conventional imaging, and pathological
data are listed in Table 1. Of those, 174 lesions were
malignant (DCIS, 22; invasive carcinoma, 152) and 124
lesions were benign (including 7 ADH, 2 ALH and 3
papillary lesions identified as high-risk lesions). The
patients with malignant lesions tended to be older than
those with benign lesions (p < 0.0001). The mean lesion
size or extension of malignant lesions on preoperative
conventional imaging studies and at surgical pathology
was significantly larger than that of the benign lesions
(Table 1). There were 215 lesions with available mam-
mographic examinations for correlation. Of the lesions
showing mammographic finding of microcalcifications,
most of them were benign. Most of the lesions with the
finding of microcalcifications with mass or noncalcified
finding were malignant (Table 1).
Univariate logistic regression analysis of the diagnostic
IR signs and the final results are shown in Table 2, and
the malignant result was significantly associated with
higher IR scores for all IR signs. However, for the age-
adjusted multivariate regression analysis, only IR1, IR4
and IR5 remained statistically significant; and IR2 and
IR3 turned out to be non-significant (Table 2). The
Hosmer and Lemeshow test revealed a non-significant p
value (p = 0.496), suggesting that the age-adjusted mul-
tivariate regression model was an acceptable, fitted
model.
When investigating the diagnostic performance of
each individual IR sign (Table 3), the IR5 revealed a
highest AUC value among the five IR signs. However,
the AUC of the age-adjusted multivariate regression
model was 0.828 (Figure 5), which was higher than the
AUC values of any of the individual IR signs; and its
lower bound of 95% CI was higher than the upper
bound of the 95% CI of the AUC of all of the individual
IR signs (Table 3). The intercept and regression coeffi-
cients of the age-adjusted multivariate regression model
are shown in Table 3. The selected cut-off values from
the age-adjusted multivariate regression model with the
derived sensitivities, specificities, PPV, NPV and You-
den’s Index are presented in Table 4. The highest You-
den’s Index was 0.49 (most optimal cut-off point), when
the cut-off value was 0.3 with a sensitivity of 72.4%, spe-
cificity of 76.6%, PPV of 81.3% and NPV of 66.4% for
the overall study population. According to the selection
criteria we established, the lowest cut-off value of this
model was -0.72, with its corresponding sensitivity
92.0%, specificity 44.3%, PPV 69.9% and NPV 79.7%; the
highest cut-off value was 1.27, and its corresponding
specificity was 94.3% at a sensitivity of 50.0%, PPV
92.6%, NPV 57.4%. The estimation of ln(OD) value for a
malignant lesion and the corresponding IR, mammo-
graphic images are illustrated in Figures 3, 4.
When we used the ln(OD) value of 0.3 as the most
optimal cut-off point, the corresponding sensitivity, spe-
cificity in each BI-RADS® category are shown in Table 5.
For the BI-RADS® category 3 lesions, IR imaging cor-
rectly identified the only 1 cancerous lesion (sensitivity
100%) with a specificity of 75% (6/8). In BI-RADS® cate-
gory 4B findings, the IR imaging correctly identified
highest proportion of true-negative lesions (specificity
84.6%, 33/39) compared with other categories but the
sensitivity (51.5%, 17/33) was somewhat lower than the
other categories (Table 5).
On the other hand, when we used the -0.72 as the
cut-off point, the sensitivity in each BI-RADS® category
increased while the specificity decreased when compared
with the counterparts using 0.3 as the cut-off point
(Table 5). Of them, in BI-RADS® category 3 findings, the
IR imaging again can identify the only one cancerous
Table 1 Clinical and conventional imaging findings.
Basic findings Malignant Benign p value
Patient (lesion) number 165 (174) 111 (124)
Age of patients (years) 54.3 (SD 11.1) 45.4(11.2) <0.0001
#
Mammographic findings 122
§ 93
Microcalcifications 28 77 <0.0001
##
Calcifications+mass* 40 3
Noncalcified lesion 51 13
Available ultrasound findings relevant
to the lesion sites
125
§§ 64
Imaging size**, cm (range) 2.83 (0.3-11) 1.94 (0.24-10) <0.0001
#
Pathologic size, cm (range) 2.88 (0.3-12) 2.15 (0.2-7.0) 0.001
#
*Lesions revealing calcifications associated with mass, focal asymmetry or architectural distortion.
**Lesion size determined by the largest diameter between mammography and breast ultrasound.
§: 3 cancerous lesions were not shown on mammograms (false-negative).
§§: 2 cancerous lesions were negative on ultrasound.
# Student’s t-test;
##: Fisher’s Exact Test.
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responding sensitivity of the BI-RADS® category 4A
findings was lowest (81.8%, 9/11) among all categories
with a specificity of 36.7% (22/60). The specificity in BI-
RADS® category 4B (56.4%, 22/39) was higher than
other categories with a sensitivity of 84.8% (28/33), and
the sensitivities in BI-RADS® categories 4C and 5 were
higher than 90%.
For all of the 298 lesions, the mean ln(OD) value of
the malignant lesions (1.40) based on the age-adjusted
multivariate model was higher than that of benign
lesions (mean ln(OD) = -0.58) with statistically signifi-
cant difference (p < 0.0001, Student’s t-test). We further
estimated the ln(OD) values for lesions with mammo-
graphic findings available for correlation. For the lesions
showing microcalcifications on mammograms, the mean
ln(OD) value of malignant lesions (mean = 0.73) was
significantly higher than that of benign lesions (mean =
-0.4; p =0 . 0 0 1 ,S t u d e n t ’s t-test). For the lesions
revealing calcifications with mass, the malignant lesions
tended to have higher ln(OD) values (median = 1.01)
than benign lesions (median = -0.63) with statistically
significant difference (p < 0.01, Mann-Whitney U test).
For lesions with noncalcified findings, the malignant
lesions again tended to have higher ln(OD) values (med-
i a n=1 . 3 5 )t h a nb e n i g nl e s i o n s( m e d i a n=0 . 2 3 ;p =
0.002, Mann-Whitney U test).
For the lesions stratified by different pathologic size
categories, the ln(OD) values of the malignant lesions
tended to be higher than those of benign lesions with
statistically significant difference in all three categories
(Table 6).
Table 2 Analysis of IR signs and the final results by univariate and age-adjusted multivariate logistic regression.
IR signs scores M B p* Univariate
#OR
(95%CI)(p**)
##Multivariate
#OR
(95%CI)(p**)
IR1 0 68 93 <0.0001 1 1
1 66 27 3.3(1.9-5.8)(<0.0001) 1.5(0.7-2.9) (0.29)
2 40 4 13.7(4.7-40.0)
(<0.0001)
6.8(2.0-23.5)(0.003)
IR2 0 70 78 0.0001 1 1
1 104 46 2.5(1.6-4.0)(0.0001) 1.2(0.6-2.3) (0.61)
IR3
& 174 124 - 1.4(1.2-1.7)(<0.0001) 1.2(0.95-1.4)(0.13)
IR4 0 140 114 <0.01 1 1
1 34 10 2.8(1.3-5.8)(<0.01) 2.8(1.1-6.8)(0.024)
IR5 0 38 77 <0.0001 1 1
1 136 47 5.9(3.5-9.8)(<0.0001) 2.8(1.4-5.8)(0.005)
M: malignant lesions; B: benign lesions; CI: confidence interval.
#OR: odds ratio;
##multivariate: age-adjusted multivariate regression model.
&: continuous variable.
p: p value estimated by *Chi-square test, **logistic regression analysis.
Table 3 AUC values for each IR sign and for an age-
adjusted multivariate logistic regression model.
model AUC 95%CI
Univariate
IR1 0.699 (0.639, 0.758)
IR2 0.613 (0.549, 0.678)
IR3 0.674 (0.611, 0.736)
IR4 0.557 (0.492, 0.623)
IR5 0.701 (0.640, 0.763)
Multivariate
(age-adjusted) 0.828 (0.783, 0.873)
Multivariate: age-adjusted multivariate regression model, which is shown as
below:
ln(odds) = ln(OD) = a+b0(Age)+b1A(IR1A)+ b1B(IR1B)+b2(IR2)+b3(IR3)+b4(IR4)+b5
(IR5)
= -5.463+0.0872(Age)+0.3783(IR1A)+1.9157(IR1B)+0.1728(IR2)+0.1578(IR3)
+1.0278(IR4)+1.0363(IR5).
Figure 5 The ROC of an age-adjusted multivariate regression
model. AUC = 0.828.
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Though infrared imaging of the breast is not widely
used for various reasons, it has been reported to show
promising results in some series [6,7,9-12,15,20]. Par-
isky, et al [6] used computerized IR imaging for suspi-
cious findings on mammograms, and reported that IR
imaging featured a relatively high sensitivity (97-99%)
and negative predictive value (95-99%) and thus can dif-
ferentiate benign from malignant lesions reliably. How-
ever, the reported specificity in this series ranged from
14 to 18%, which was relatively low. Keyserlingk, et al
[7] reported that the sensitivity of mammography alone
was 85% and that of combined modalities of digital IR,
mammography was 95%. Thus, digital IR imaging can
provide additional information for breast lesion diagno-
sis. There were some authors from different series who
used an artificial neural network, computer software, or
segmentation technique for breast cancer detection,
monitoring of treatment response, and for establishing
an interpretive model [3,5,11,12,15,20]. However, though
digital IR imaging uses the combined criteria of tem-
perature and vascular pattern for diagnosis, the
Table 4 The cut-off points, sensitivity, specificity and Youden’s Index derived from an age-adjusted multivariate
regression model.
Cut-off* Sen (%) Spe (%) Youden PPV (%) NPV (%)
1.27 50.0 94.3 0.443 92.6 57.4
0.82 62.6 84.7 0.473 85.2 61.8
0.30
# 72.4 76.6 **0.490 81.3 66.4
-0.30 85.6 57.3 0.429 73.8 74.0
-0.72 92.0 44.3 0.363 69.9 79.7
*Cut-off: cut-off values, derived from ln(odds), which is the natural logarithm of the odds (OD) from the age-adjusted multivariate regression model. A lesion with
a ln(OD) value higher than or equal to a given cut-off point is regarded as IR test-positive.
Sen: sensitivity; Spe: specificity; Youden: Youden’s Index = sensitivity+specificity-1.
PPV: positive predictive value; NPV: negative predictive value.
** highest Youden’s Index value (
#the most optimal cut-off point we selected from the model).
The cut-off value was -3.51 when the sensitivity was 100% and the specificity 0%; it was 5.47 when the sensitivity was 0.57% and specificity 100% (not shown in
the table because they didn’t meet the selection criteria of cut-off points in our study).
Table 5 The correlation of BI-RADS® categories on conventional imaging and the corresponding diagnostic perfor-
mance of IR imaging based on the two cut-off points (0.30 and - 0.72)
†BI-RADS®
(
‡n = 281)
True status
(n)
Cut-off (1)
ln(OD)
Sen(%) Spe(%) Cut-off (2)
ln(OD)
Sen(%) Spe(%)
>=0.30 <0.30 >= -0.72 <-0.72
3 (n = 9) B (n = 8) 2 6 100 75.0 4 4 100 50.0
M(n = 1) 1 0 1 0
4A (n = 71) B(n = 60) 15 45 54.5 75.0 38 22 81.8 36.7
M(n = 11) 6 5 9 2
4B (n = 72) B (n = 39) 6 33 51.5 84.6 17 22 84.8 56.4
M(n = 33) 17 16 28 5
4C (n = 95) B (n = 10) 4 6 74.1 60.0 6 4 92.9 40.0
M (n = 85) 63 22 79 6
5 (n = 34) B (n = 2) 2 0 81.3 0 2 0 100 0
M (n = 32) 26 6 32 0
†BI-RADS®: BI-RADS® category, an integrated BI-RADS category assessment based on conventional imaging (mammography and/or ultrasound), accordingt o
higher concern in any of or the two combined imaging modalities.
‡There were 17 lesions from 17 patients having outside mammography and/or ultrasound and the detailed statements of BI-RADS® categories were not obtained,
and thus leaving 281 lesions for evaluation.
BI-RADS® Category 3: probably benign finding.
BI-RADS® Category 4A: a lesion with low suspicion level for malignancy.
BI-RADS® Category 4B: a lesion with intermediate concern for malignancy.
BI-RADS® Category 4C: a lesion with moderate concern for malignancy.
BI-RADS® Category 5: a lesion which is highly suggestive of malignancy.
B: benign (including high-risk lesions); M: malignant.
Cut-off (1): the cut-off value of 0.30; cut-off (2): the cut-off value of -0.72.
ln(OD)>= the selected cut-off value indicated IR-test positive, and < the cut-off value indicated IR-test negative; ln(OD): ln(odds).
Sen: sensitivity = (true-positive number)/(the number of malignant disease status); while true- positive indicated IR-test positive as well as disease positive
(malignant).
Spe: specificity = (true-negative number)/(the number of benign disease status); while true-negative indicated IR-test negative as well as disease negative (benign
or high risk lesions).
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Page 7 of 10diagnostic criteria are still somewhat variable according
to the aforementioned series [3,5,7,11,12,15,20]. In our
study, for a subpopulation with diagnostic purpose, we
tried to establish an age-adjusted multivariate regression
model to predict breast cancer disease status based on
IR findings, and to investigate the diagnostic perfor-
mance of IR imaging based on this model.
For univariate analysis of the different diagnostic IR
signs in our study, we found that there was a significant
association between malignancy and higher IR scores for
each IR sign, and the IR5 (asymmetric vascular pattern
at lesion site compared to the contralateral side) showed
a higher AUC value than other signs. This was not sur-
prising, since IR imaging of the breast was designed to
detect temperature elevations of the tumor, and the site
with elevated surface temperature will indeed cause an
asymmetric thermographic pattern. Therefore, though
the IR1 sign has a somewhat similar implication as IR5,
it is a quantitative measure, while IR5 is a morphologi-
cally descriptive sign. In addition, for a better compari-
son of the lesion site with the contralateral breast, we
excluded women who had breast surgery previously, to
eliminate the inherent asymmetric thermographic pat-
tern due to parenchymal loss after partial or total
mastectomy.
In age-adjusted multivariate regression analysis, the
malignant result was associated with higher IR scores,
especially for IR1, IR4 and IR5 when adjusted for other
factors. Indeed, this model revealed a better diagnostic
performance when compared with each IR sign from
univariate analysis, based on a diagnostic population in
our study. Though there were some series reporting the
diagnostic value of IR imaging for breast cancer screen-
ing [1,4,9,21,22], and abnormal IR imaging of the breast
was reported to be a cancer risk predictor [9], IR ima-
ging has not been routinely used for screening purpose.
Our study, like some of other series [6,7,11], investigated
the diagnostic efficacy of IR imaging for specific groups
with inconclusive or suspicious findings on conventional
imaging modalities (mammography or ultrasound). In
addition, most of these reported series combined the
mammographic, clinical breast examination and IR
together to discuss the diagnostic values of IR as an
adjunct tool. But these series seldom included ultrasono-
graphic correlation [6-8,11]. However, in our study,
there was a considerable proportion of participants that
had mammographic and ultrasonographic correlations,
and a combined analysis of both imaging modalities
would provide a more convincing diagnostic result than
if only one of the modalities was available. Therefore,
we designed our study so that the interpreting radiolo-
gists were informed of only the lesion site and size on
conventional imaging modalities when reading the IR
images, and were blinded to the clinical history and
detailed mammographic and ultrasonographic findings,
and the pathological results. We established this proto-
col to ensure a more objective reading of IR images.
This allowed us to establish an interpretive model for IR
imaging of the breast with less bias. After establishing
an appropriate interpretive model, it would be possible
to apply this model or similar methodology to other
groups, such as a screening population.
In our study, the cut-off values of the IR imaging were
estimated from the age-adjusted multivariate regression
model, which also derived the AUC of the ROC curve
for diagnostic performance evaluation, and the various
sets of sensitivity and specificity values can be inferred
from different cut-off values. There is always a trade-off
between sensitivity and specificity, since a higher sensi-
tivity will be accompanied with a lower specificity and
vice versa. The above observations also apply to the ana-
lysis of PPV and NPV. As can be seen in Table 4, cut-
off values with higher PPV and specificity correspond to
a lower NPV and sensitivity, and vice versa. The strategy
of which arm should be stressed more depends on the
purpose of the test and the target population enrolled
[17,18,23]. Under this consideration, the cut-off value
with the highest Youden’s Index might not be the most
optimal threshold value [17,18,23]. For the lowest
selected cut-off point (sensitivity 92.0% and specificity
44.3%) in our study, it showed a relatively high sensitiv-
ity and an acceptable specificity when compared with
other reported series [6,11]. However, in BI-RADS® cate-
gory 3 findings, the cut-off point with highest Youden’s
Index (cut-off value 0.3) yielded a high sensitivity and
moderate specificity (75%), but the specificity dropped
to 50% when using the -0.72 as the cut-off point. There-
fore, for the IR imaging, the cut-off value of 0.3 was a
more optimal cut-off point for probably benign findings
as an adjunct role in diagnostic breast imaging. And for
Table 6 The ln(odds) values (ln(OD)) between benign and
malignant lesions stratified by size
M
† B
‡ p
size*(cm)>= 2
n 111 51
ln(OD) 1.65
a -0.61
a < 0.001
#
1 <= size*(cm)<2
n4 6 2 7
ln(OD) 1.20
a -0.74
a < 0.001
#
size*(cm)<1
n1 7 4 6
ln(OD) 0.36
a -0.62
m < 0.028
§
†M: malignant;
‡B: benign (including high-risk lesions); ln(OD): ln(odds).
*size: determined by the pathologic size (across the largest diameter).
a: Average, mean ln(OD).
m: Median ln(OD).
#: Student’s t-test;
§: Mann-Whitney U test.
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Page 8 of 10the category 4A and 4B findings, though the sensitivities
using the -0.72 as the cut-off point increased as com-
pared with the cut-off point of 0.3, the values (81.8% in
4A and 84.8% in 4B; Table 5) were still not satisfactory
in a diagnostic population. However, if we read the IR
imaging after viewing the detailed mammographic and
ultrasound images, the diagnostic performance may be
different and should be likelye l e v a t e ds o m e w h a tc o m -
pared with our current study design. In that situation,
the clinical role of IR imaging may be more enhanced at
the help with decision making when the mammography
or ultrasound shows ambiguous findings.
In our study, for the lesions with mammographic find-
ings available for correlation, we found that the malig-
nant lesions tended to have higher ln(OD) values (ln
(odds) values) than benign lesions in all three types of
mammographic findings.
When we compared the ln(OD) values between the
benign and malignant lesions stratified by different
pathologic size categories, we found that the malignant
lesions tended to have higher ln(OD) values than benign
lesions in all three categories, even for lesions less than
1 cm and 2 cm in size. The findings further ensure the
validity of application of the age-adjusted multivariate
model to lesions with smaller tumor size.
There are some limitations to our study. First, as we
stated previously, our study participants were for diag-
nostic purpose, and we interpreted the IR images refer-
ring to the lesion site and size, that is, a targeted
interpretation. Therefore, currently we have not yet
documented the diagnostic value of our model for
screening purposes. Second, for the purpose of keeping
the statistical efficiency of the model analysis, we cate-
gorized 12 high-risk lesions into the benign group due
to the limited sampling size, and we didn’t further cate-
gorize the malignant lesions into non-invasive and inva-
sive, or different grades of carcinomas. Therefore, the
diagnostic performance of IR imaging in high-risk
lesions or different pathologic grades of carcinomas may
not be known. Finally, we excluded patients having a
past history of breast surgery to reduce the interpreta-
tion bias caused by asymmetric thermographic pattern
due to parenchymal loss, as we mentioned above. Thus,
we haven’t applied our interpretative model to post-
operative breasts.
Conclusions
In conclusion, IR imaging of the breast is a noninvasive
diagnostic examination. We established an age-adjusted
multivariate logistic regression model under a specific
clinical setting for diagnostic purpose. However, its
values for post-operative breasts, for screening popula-
tions, and for high-risk lesions or different grades of
breast carcinomas have not been verified in our study
and should be further investigated in the future. Further,
from our study, it has not yet been proven whether the
IR imaging would reliably avoid unnecessary biopsy for
suspicious findings on mammograms and breast
ultrasound.
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